Table 3. Cox model with hazard ratios and 95% confidence intervals of COPD associated with systemic lupus erythematosus and covariates.
Crude | Adjusted† | |||
Variable | HR | (95% CI) | HR | (95% CI) |
Age | ||||
20–34 years | 1 | (Reference) | 1 | (Reference) |
35–49 years | 3.74 | (1.99, 7.03)*** | 3.62 | (1.93, 6.79)*** |
50–64 years | 12.1 | (6.63, 22.2)*** | 9.03 | (4.90, 16.6)*** |
65+ years | 115.6 | (66.0, 202.3)*** | 61.9 | (34.7, 110.7)*** |
Sex | ||||
Male | 4.38 | (3.48, 5.50)*** | 2.33 | (1.84, 2.94)*** |
Female | 1 | (Reference) | 1 | (Reference) |
Baseline comorbidities (yes vs no) | ||||
SLE | 1.72 | (1.36, 2.19)*** | 1.82 | (1.43, 2.31)*** |
Hypertension | 9.53 | (7.66, 11.8)*** | 1.28 | (0.97, 1.68) |
Diabetes | 9.17 | (7.20, 11.7)*** | 1.52 | (1.16, 1.99)** |
Hyperlipidemia | 4.34 | (3.06, 6.17)*** | 0.87 | (0.60, 1.26) |
CAD | 13.1 | (10.3, 16.7)*** | 1.86 | (1.41, 2.45)*** |
CVA | 12.2 | (9.56, 15.6)*** | 1.99 | (1.51, 2.620*** |
ESRD | 2.20 | (1.09, 4.43)* | 0.67 | (0.33, 1.36) |
Adjusted HR: multivariable analysis including for age, sex,
hypertension, diabetes, hyperlipidemia, CAD, CVA, and ESRD.
*p<0.05, ** p<0.01, *** p<0.001.